entecavir tablets

DRUG3 trials

Sponsors

Sunshine Lake Pharma Co., Ltd., Ou Bai, MD/PHD

Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)Hepatitis B, Chronic

Phase 1

Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

TerminatedNCT04536532

Sunshine Lake Pharma Co., Ltd.Hepatitis B, Chronic

Start: 2020-10-09End: 2023-03-12Updated: 2024-06-24

Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

CompletedNCT05391360

Sunshine Lake Pharma Co., Ltd.Hepatitis B, Chronic

Start: 2021-10-11End: 2023-01-17Updated: 2023-04-12

Phase 3

Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

RecruitingNCT07493109

Ou Bai, MD/PHDDiffuse Large B-Cell Lymphoma (DLBCL)

Start: 2026-05-30End: 2030-09-30Target: 200Updated: 2026-03-25

Related Papers

Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients

Liver International2024-12-143 citations